COVID-19 Impact on Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

August 2020 | 131 pages | ID: CDE977AEF0E3EN
QYResearch

Abstracts

This report focuses on the global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AbbVie
• Celgene
• Kite Pharma
• Oxford BioMedica
• Novartis
• Gilead
• Pfizer
• Cellectis
• Bellicum
• Mustang Bio
• CARsgen Therapeutics
• Xyphos
• Minerva Biotechnologies
• Adaptimmune
• Ziopharm Oncology
• Aurora Biopharma
• Creative Biolabs

Market segment by Type, the product can be split into

• Monotherapy
• Combination Therapy

Market segment by Application, split into

• Hematologic Malignancies
• Solid Malignancies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players.
• To present the CAR T-Cell Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of CAR T-Cell Immunotherapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monotherapy
  1.4.3 Combination Therapy
1.5 Market by Application
  1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
  1.5.2 Hematologic Malignancies
  1.5.3 Solid Malignancies
1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the CAR T-Cell Immunotherapy Industry
    1.6.1.1 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 CAR T-Cell Immunotherapy Market Perspective (2015-2026)
2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
  2.2.1 CAR T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 CAR T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
  2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 CAR T-Cell Immunotherapy Market Growth Strategy
  2.3.6 Primary Interviews with Key CAR T-Cell Immunotherapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top CAR T-Cell Immunotherapy Players by Market Size
  3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2015-2020)
  3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CAR T-Cell Immunotherapy Market Concentration Ratio
  3.2.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2019
3.3 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.4 Key Players CAR T-Cell Immunotherapy Product Solution and Service
3.5 Date of Enter into CAR T-Cell Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)

5 CAR T-CELL IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America CAR T-Cell Immunotherapy Market Size (2015-2020)
6.2 CAR T-Cell Immunotherapy Key Players in North America (2019-2020)
6.3 North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
6.4 North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe CAR T-Cell Immunotherapy Market Size (2015-2020)
7.2 CAR T-Cell Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
7.4 Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

8 CHINA

8.1 China CAR T-Cell Immunotherapy Market Size (2015-2020)
8.2 CAR T-Cell Immunotherapy Key Players in China (2019-2020)
8.3 China CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
8.4 China CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan CAR T-Cell Immunotherapy Market Size (2015-2020)
9.2 CAR T-Cell Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
9.4 Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2015-2020)
10.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

11 INDIA

11.1 India CAR T-Cell Immunotherapy Market Size (2015-2020)
11.2 CAR T-Cell Immunotherapy Key Players in India (2019-2020)
11.3 India CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
11.4 India CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America CAR T-Cell Immunotherapy Market Size (2015-2020)
12.2 CAR T-Cell Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie
  13.1.1 AbbVie Company Details
  13.1.2 AbbVie Business Overview and Its Total Revenue
  13.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
  13.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020))
  13.1.5 AbbVie Recent Development
13.2 Celgene
  13.2.1 Celgene Company Details
  13.2.2 Celgene Business Overview and Its Total Revenue
  13.2.3 Celgene CAR T-Cell Immunotherapy Introduction
  13.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.2.5 Celgene Recent Development
13.3 Kite Pharma
  13.3.1 Kite Pharma Company Details
  13.3.2 Kite Pharma Business Overview and Its Total Revenue
  13.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
  13.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.3.5 Kite Pharma Recent Development
13.4 Oxford BioMedica
  13.4.1 Oxford BioMedica Company Details
  13.4.2 Oxford BioMedica Business Overview and Its Total Revenue
  13.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
  13.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.4.5 Oxford BioMedica Recent Development
13.5 Novartis
  13.5.1 Novartis Company Details
  13.5.2 Novartis Business Overview and Its Total Revenue
  13.5.3 Novartis CAR T-Cell Immunotherapy Introduction
  13.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.5.5 Novartis Recent Development
13.6 Gilead
  13.6.1 Gilead Company Details
  13.6.2 Gilead Business Overview and Its Total Revenue
  13.6.3 Gilead CAR T-Cell Immunotherapy Introduction
  13.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.6.5 Gilead Recent Development
13.7 Pfizer
  13.7.1 Pfizer Company Details
  13.7.2 Pfizer Business Overview and Its Total Revenue
  13.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
  13.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.7.5 Pfizer Recent Development
13.8 Cellectis
  13.8.1 Cellectis Company Details
  13.8.2 Cellectis Business Overview and Its Total Revenue
  13.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
  13.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.8.5 Cellectis Recent Development
13.9 Bellicum
  13.9.1 Bellicum Company Details
  13.9.2 Bellicum Business Overview and Its Total Revenue
  13.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
  13.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.9.5 Bellicum Recent Development
13.10 Mustang Bio
  13.10.1 Mustang Bio Company Details
  13.10.2 Mustang Bio Business Overview and Its Total Revenue
  13.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
  13.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  13.10.5 Mustang Bio Recent Development
13.11 CARsgen Therapeutics
  10.11.1 CARsgen Therapeutics Company Details
  10.11.2 CARsgen Therapeutics Business Overview and Its Total Revenue
  10.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
  10.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.11.5 CARsgen Therapeutics Recent Development
13.12 Xyphos
  10.12.1 Xyphos Company Details
  10.12.2 Xyphos Business Overview and Its Total Revenue
  10.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
  10.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.12.5 Xyphos Recent Development
13.13 Minerva Biotechnologies
  10.13.1 Minerva Biotechnologies Company Details
  10.13.2 Minerva Biotechnologies Business Overview and Its Total Revenue
  10.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
  10.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.13.5 Minerva Biotechnologies Recent Development
13.14 Adaptimmune
  10.14.1 Adaptimmune Company Details
  10.14.2 Adaptimmune Business Overview and Its Total Revenue
  10.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
  10.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.14.5 Adaptimmune Recent Development
13.15 Ziopharm Oncology
  10.15.1 Ziopharm Oncology Company Details
  10.15.2 Ziopharm Oncology Business Overview and Its Total Revenue
  10.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
  10.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.15.5 Ziopharm Oncology Recent Development
13.16 Aurora Biopharma
  10.16.1 Aurora Biopharma Company Details
  10.16.2 Aurora Biopharma Business Overview and Its Total Revenue
  10.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
  10.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.16.5 Aurora Biopharma Recent Development
13.17 Creative Biolabs
  10.17.1 Creative Biolabs Company Details
  10.17.2 Creative Biolabs Business Overview and Its Total Revenue
  10.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
  10.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
  10.17.5 Creative Biolabs Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. CAR T-Cell Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
Table 3. Ranking of Global Top CAR T-Cell Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. COVID-19 Impact Global Market: (Four CAR T-Cell Immunotherapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for CAR T-Cell Immunotherapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
Table 12. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global CAR T-Cell Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global CAR T-Cell Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Market Share by Regions (2015-2020)
Table 16. Global CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global CAR T-Cell Immunotherapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. CAR T-Cell Immunotherapy Market Growth Strategy
Table 22. Main Points Interviewed from Key CAR T-Cell Immunotherapy Players
Table 23. Global CAR T-Cell Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global CAR T-Cell Immunotherapy Market Share by Players (2015-2020)
Table 25. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019)
Table 26. Global CAR T-Cell Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players CAR T-Cell Immunotherapy Product Solution and Service
Table 29. Date of Enter into CAR T-Cell Immunotherapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global CAR T-Cell Immunotherapy Market Size Share by Type (2015-2020)
Table 33. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2021-2026)
Table 34. Global CAR T-Cell Immunotherapy Market Size Share by Application (2015-2020)
Table 35. Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global CAR T-Cell Immunotherapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 39. North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 41. North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 43. Europe Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 45. Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 47. Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 49. China Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 51. China CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 52. China CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 53. China CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 54. China CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 55. Japan Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 57. Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 59. Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 63. Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 65. Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 67. India Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 69. India CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 70. India CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 71. India CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 72. India CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 75. Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 77. Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Product
Table 87. Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 88. Celgene Recent Development
Table 89. Kite Pharma Company Details
Table 90. Kite Pharma Business Overview
Table 91. Kite Pharma Product
Table 92. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 93. Kite Pharma Recent Development
Table 94. Oxford BioMedica Company Details
Table 95. Oxford BioMedica Business Overview
Table 96. Oxford BioMedica Product
Table 97. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 98. Oxford BioMedica Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Gilead Company Details
Table 105. Gilead Business Overview
Table 106. Gilead Product
Table 107. Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 108. Gilead Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Product
Table 112. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 113. Pfizer Recent Development
Table 114. Cellectis Business Overview
Table 115. Cellectis Product
Table 116. Cellectis Company Details
Table 117. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 118. Cellectis Recent Development
Table 119. Bellicum Company Details
Table 120. Bellicum Business Overview
Table 121. Bellicum Product
Table 122. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 123. Bellicum Recent Development
Table 124. Mustang Bio Company Details
Table 125. Mustang Bio Business Overview
Table 126. Mustang Bio Product
Table 127. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 128. Mustang Bio Recent Development
Table 129. CARsgen Therapeutics Company Details
Table 130. CARsgen Therapeutics Business Overview
Table 131. CARsgen Therapeutics Product
Table 132. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 133. CARsgen Therapeutics Recent Development
Table 134. Xyphos Company Details
Table 135. Xyphos Business Overview
Table 136. Xyphos Product
Table 137. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 138. Xyphos Recent Development
Table 139. Minerva Biotechnologies Company Details
Table 140. Minerva Biotechnologies Business Overview
Table 141. Minerva Biotechnologies Product
Table 142. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 143. Minerva Biotechnologies Recent Development
Table 144. Adaptimmune Company Details
Table 145. Adaptimmune Business Overview
Table 146. Adaptimmune Product
Table 147. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 148. Adaptimmune Recent Development
Table 149. Ziopharm Oncology Company Details
Table 150. Ziopharm Oncology Business Overview
Table 151. Ziopharm Oncology Product
Table 152. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 153. Ziopharm Oncology Recent Development
Table 154. Aurora Biopharma Company Details
Table 155. Aurora Biopharma Business Overview
Table 156. Aurora Biopharma Product
Table 157. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 158. Aurora Biopharma Recent Development
Table 159. Creative Biolabs Company Details
Table 160. Creative Biolabs Business Overview
Table 161. Creative Biolabs Product
Table 162. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 163. Creative Biolabs Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
Figure 5. Hematologic Malignancies Case Studies
Figure 6. Solid Malignancies Case Studies
Figure 7. CAR T-Cell Immunotherapy Report Years Considered
Figure 8. Global CAR T-Cell Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global CAR T-Cell Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 10. Global CAR T-Cell Immunotherapy Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global CAR T-Cell Immunotherapy Market Share by Players in 2019
Figure 13. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2019
Figure 15. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 24. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 26. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 28. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 32. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 36. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 38. Bellicum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 40. Mustang Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 42. CARsgen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 44. Xyphos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 46. Minerva Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 48. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 50. Ziopharm Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 52. Aurora Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 54. Creative Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed